Inhaled steroids beneficial for patients with cystic fibrosisAccording to a finding presented in an issue of the American Journal of Respiratory and Critical Care Medicine and published by the American Thoracic Society, there is no difference in terms of benefits when comparisons are made between cystic fibrosis (CF) patients on inhaled corticosteroids and those who didn’t use inhaled steroids for six months.

Ian M. Balfour-Lynn, M.D., F.R.C.P., of the Department of Pediatric Respiratory Medicine at Royal Brompton Hospital in London, and six associates concluded that it is safe for the patients to stop using corticosteroids for lowering their drug burden, save money, and minimize adverse side effects.

Dr. Balfour-Lynn remarked that replacing the corticosteroids with a placebo was safe as it did not led to a significant increase in lung-related adverse effects leading to withdrawal from the study, nor an increased need for oral corticosteroids.